dc.creatorPérez M.J.
dc.creatorPonce D.P.
dc.creatorOsorio-Fuentealba C.
dc.creatorBehrens M.I.
dc.creatorQuintanilla R.A.
dc.date.accessioned2020-09-02T22:25:46Z
dc.date.accessioned2022-11-08T20:19:37Z
dc.date.available2020-09-02T22:25:46Z
dc.date.available2022-11-08T20:19:37Z
dc.date.created2020-09-02T22:25:46Z
dc.date.issued2017
dc.identifier11, OCT, -
dc.identifier16624548
dc.identifierhttps://hdl.handle.net/20.500.12728/5772
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5143255
dc.languageen
dc.publisherFrontiers Media S.A.
dc.subjectAlzheimer's disease
dc.subjectBiomarker
dc.subjectFibroblasts
dc.subjectMitochondria
dc.subjectOPA1
dc.subjectoptic atrophy 1 protein
dc.subjectregulator protein
dc.subjectunclassified drug
dc.subjectadult
dc.subjectaged
dc.subjectAlzheimer disease
dc.subjectArticle
dc.subjectbioenergy
dc.subjectbrain mitochondrion
dc.subjectcell fusion
dc.subjectcell structure
dc.subjectcontrolled study
dc.subjectdiagnostic test
dc.subjectdisease marker
dc.subjectdisorders of mitochondrial functions
dc.subjecthuman
dc.subjecthuman cell
dc.subjecthuman cell culture
dc.subjectmiddle aged
dc.subjectprotein degradation
dc.subjectprotein expression
dc.subjectprotein processing
dc.subjectskin fibroblast
dc.subjectvery elderly
dc.titleMitochondrial bioenergetics is altered in fibroblasts from patients with sporadic Alzheimer's disease
dc.typeArticle


Este ítem pertenece a la siguiente institución